About the Human Albumin Market
Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer’s disease) are expected to enter the market during the forecast period.
The demand for albumin is high in APAC in countries like India and China. Still, the uptake of these therapeutics is less due to the lack of awareness about these products and their therapeutic uses. Thus, the awareness programs conducted by organizations such as PPTA, which includes International Plasma Awareness Week, to help increase the awareness about plasma donation and the different plasma protein therapies available, along with their potential uses, is expected to increase the uptake of these therapeutics in treating various conditions.
Technavios analysts forecast the global human albumin market to grow at a CAGR of 4.97% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global human albumin market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic albumin drugs used to treat infections, liver diseases, shock, during surgery, and severe burns. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched in the market along with the decline in revenues from the genericization of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
Technavio’s report, Global Human Albumin Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Download Sample Copy of Report at http://www.marketresearchreports.biz/sample/sample/745953
Key vendors
CSL Behring
Grifols
Baxalta
Octapharma
Kedrion
Other prominent vendors
AADi
Ablynx
Albumedix
Ampio Pharmaceuticals
Azaya Therapeutics
Beijing Tiantan
Biotest
Bristol-Myers Squibb
Celgene
ConjuChem
GSK
Hebei Changshan Biochem Pharma
HiMedia Laboratories
Hualan Biological Engineering
InVittria
MedxBio
Merck
Mitsubishi Tanabe Pharma
NantBioScience
Novo Nordisk
Novozymes
Shanghai RAAS Blood Products
Sucampo Pharmaceuticals
Teva Pharmaceuticals
Thermo Fisher Scientific
Tianjin SinoBiotech & Beijing Bio-Fortune
Ventria Bioscience
Yoshitomi Pharmaceutical
Market driver
High demand for human albumin in China
For a full, detailed list, view our report
Market challenge
Spread of pathogenic contaminants
For a full, detailed list, view our report
Market trend
Rise in non-therapeutic applications
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?